Comparison of Body Mass Index and Metabolic Score for Viscer... | Clinical Trial | StuddyBuddy@endsection Comparison of Body Mass Index and Metabolic Score for Visceral Adiposity in Evaluation of Visceral Adiposity
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05648409

Comparison of Body Mass Index and Metabolic Score for Visceral Adiposity in Evaluation of Visceral Adiposity

Conditions: Visceral Obesity

Sex: All
Ages: 20 Years – 50 Years
Healthy volunteers: 1
Enrollment: 194
Sponsor: Goztepe Prof Dr Suleyman Yalcın City Hospital

Location: Turkey

Summary

Visceral obesity is a major risk factor for cardiometabolic diseases such as type 2 diabetes, hypertension, and coronary artery disease. In clinical settings and during research, "body mass index (BMI)" is usually used for assessing obesity, and when it is above 30 kg/m2, it is defined as obesity. However, the risk posed by obesity is more related to body fat distribution than total body fat, and BMI only reflects the second. Individuals with a BMI below 30, even 25, may still have visceral adiposity detectable via an abdominal computerized tomography ( CT) or magnetic resonance imaging (MRI). Therefore new, practical, inexpensive parameters are needed to evaluate visceral adiposity. "Metabolic Score for Visceral Adiposity (METS-VF)", "Body Shape Index (BSI)", "Conicity Index (CI)" and "Body Roundness Index (BRI)" are a few recent indexes developed trying to fulfill these needs. The aim is to investigate the effectivity of METS-VF in comparison with BMI, BSI, CI, and BRI in reflecting visceral adiposity assessed with CT.

Eligibility Criteria

Inclusion Criteria:Having consented to the workHaving a computed tomography of the abdomen taken within the last monthHaving a biochemistry analysis including lipid levels in the last three monthsNo weight loss in the last 3 monthsExclusion Criteria:Antihyperlipidemic medication usagePresence of active malignancyHaving an anatomical structure that is not suitable for taking anthropometric measurementsThe use medications that might affect metabolic values such as steroidsChronic inflammatory diseases, acute infection and other lipodystrophic syndromes (HIV etc.)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05648409). StuddyBuddy aggregates publicly available trial information.